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ABSTRACT
Purpose: Thyroglossal duct cyst is the most common congenital anomaly of the neck, and 
malignancy arising from a thyroglossal duct cyst occurs only in approximately 1% of patients. 
Ultrasound examination and fine-needle aspiration should be performed to make an accurate 
diagnosis before surgery. Sistrunk operation is known as a surgical treatment for thyroglossal 
duct cyst. We describe the clinical characteristics of thyroglossal duct cyst carcinoma in eight 
cases and the treatment methods for each.
Methods: This is a retrospective study of thyroglossal duct cyst detected in patients 
undergoing surgery at two separate tertiary medical institutions in Korea from July 2006 to 
August 2020.
Results: Among 346 patients with thyroglossal duct cyst, eight were diagnosed with 
thyroglossal duct cyst carcinoma. In four out of these eight patients, cysts and thyroid 
nodules were observed, and thyroidectomy and Sistrunk operation were performed together. 
Modified radical neck dissection was performed only in two patients with confirmed lymph 
node metastasis before surgery. All four patients who underwent total thyroidectomy and 
Sistrunk operation received radioactive iodine treatment and did not receive radiation 
therapy. None of the patients had distant metastasis.
Conclusion: Thyroglossal duct cyst carcinoma is rare, and an initial evaluation is critical in 
determining the extent of surgery. Fine needle aspiration should be performed in patients 
who are clinically diagnosed with thyroglossal duct cyst, and a thyroid ultrasound scan should 
also be performed.
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INTRODUCTION
Thyroglossal duct cysts (TGDCs) are the most common congenital anomaly of thyroid 
development that occur in infancy and childhood and mostly present as midline neck masses 
(1). In general, the thyroid gland develops as a midline endodermal invagination in the foramen 
caecum during the third week of fetal development. At 7–8 weeks of intrauterine development, 
the thyroid gland reaches its normal position under the thyroid cartilage and descends 
through the thyroglossal duct (TGD). The TGD disappears physiologically at 10 weeks of fetal 
development. The remnants of the TGD will remain as cysts, ducts, or ectopic tissue (2,3).
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Thyroid Cancer Arising from 
Thyroglossal Duct Cyst
Although the prevalence of TGDC is approximately 7%, malignancy arising from a TGDC 
occurs only in approximately 1% of patients with TGDC, and papillary thyroid cancer (PTC) 
is the most common type (4). This malignant tumor was first reported by Brentano in 1911 
(5). When a clinical diagnosis of a TGDC is made, it should be closely examined be using 
ultrasound scan, computed tomography (CT) scan, and fine-needle aspiration (FNA) test. 
Examinations for TGDC carcinoma before surgery are performed to determine the optimal 
surgical extent and to plan radioactive iodine (RAI) treatment (6).
In general, the Sistrunk operation is the surgical procedure of choice for TGDC. This 
method of removing TGDC, the central part of the hyoid bone, and the tissues around the 
thyroglossal tract is the surgery of choice for low-risk patients. However, high-risk patients 
need additional surgical resection beyond this range (2,7).
In this report, a series of a rare case of papillary carcinoma arising from a TGDC is presented, 
its clinical characteristics are investigated, and an appropriate treatment method is sought 
along with a literature review.
MATERIALS AND METHODS
A retrospective chart review study was conducted at two separate tertiary medical institutions 
in Korea. The clinical records were reviewed between July 2006 and August 2020, and 
patients with a histological diagnosis of carcinoma of TGDC were identified. The patients' 
demographics, such as age, sex, surgical method, surgical extent, preoperative FNA results, 
site of TGDC, type of carcinoma, clinical course, postoperative radio-iodine ablation, and 
follow-up, were analyzed. This study was approved by the Institutional Review Board of 
Gangnam Severance Hospital (approval No. 3-2020-0415).
RESULTS
During the research period, 346 patients underwent TGDC surgery in two separate tertiary 
care centers; eight patients were diagnosed with papillary carcinoma arising from TGDC 
and underwent surgery. The female-to-male ratio was 7:1. The average age at the time of 
surgery was 42.25 years (range, 26–68 years). In four patients, the masses were noticeable 
or palpable, while the masses in the other four patients were accidentally discovered upon 
ultrasound examination of the thyroid gland. Two patients underwent FNA due to TGDC 
prior to surgery, one of which was reported as PTC and the other as inappropriate. Four 
patients (50%) had a coexisting thyroid carcinoma, all of which were PTC. The average 
tumor size was 1.6 mm (range, 0.6–2.5 mm). Four patients received RAI treatment and no 
recurrence was reported. The average follow-up period was 42 months (range, 1–94 months) 
(Tables 1 and 2).
All patients were included in an imaging study followed by surgery. In one patient, only the 
thyroid gland was imaged, and no cyst was observed. Of the eight patients, three had normal 
thyroid glands, and the five patients had nodules. According to histopathological findings, 
out of the five patients who underwent thyroidectomy, four patients had papillary thyroid 
cancer and one patient had noninvasive follicular thyroid neoplasm with papillary-like 
nuclear features (NIFTP).
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Table 1. The image finding of TGDC, the thyroid gland, and LNs
No Operation Extent of surgery Age Sex Imaging finding
TGDC Thyroid LNs
1 MRND, left BTT with CCND 52 M Cyst not imaged Rt. thyroid with 1.5 cm lesion at 
mid portion
0.8 cm LN at Lt. 
submental area
Lt. MRND Lt. thyroid with 1.4 cm lesion 
(extrathyroidal invasion) at mid 
portion close to the esophagus and 
the trachea
0.5 cm, 0.7 cm, 1.0 cm 
LNs at Lt. level IV
Shaving off of trachea & 
RLN
Lt. isthmus with 0.4 cm lesion
2 Sistrunk 
operation
Sistrunk operation BTT 
with CCND
29 F 3 cm sized low-density cystic 
mass with calcification in 
anterior neck
Rt. thyroid with 1.0 cm lesion at 
upper portion
No nodes
3 Excision of 
thyroglossal  
duct cyst
Sistrunk operation BTT 
with CCND
26 F 3 cm cystic lesion with solid 
component in midline of 
anterior neck





Sistrunk operation 53 F 1.7 cm cystic lesion in Rt. 
midline anterior neck
Lt. isthmus with 1.0 cm lesion 1.1 cm metastatic LN at 




Sistrunk operation 28 F 1.4 cm cystic lesion with 
calcification, solid component
Normal thyroid No nodes
6 Sistrunk 
operation
Sistrunk operation 48 F 1.7 cm cystic lesion with 
calcification
Normal thyroid No nodes
7 Sistrunk 
operation
Sistrunk operation 34 F 1.5 cm ovoid hypoechoic Cystic 
lesion
Normal thyroid No nodes
8 Sistrunk 
operation
Sistrunk operation 68 F 1.1 cm cystic lesion with 
calcification
Rt. thyroid with 2.2 cm lesion at 
mid portion
No nodes
Rt. thyroidectomy with 
CCND
Lt. thyroid with multiple benign 
nodules
PTC = papillary thyroid carcinoma; CCND = central compartment lymph node dissection; TGDC = thyroglossal duct cyst; BTT = bilateral total thyroidectomy; 
MRND = modified radical neck dissection; RLN = recurrent laryngeal nerve; LN = lymph node.
Table 2. Clinicopathologic features of the patients in this case series
No Extent of surgery Location Symptoms FNA Tumor 
size 
(cm)
TGDC pathology Thyroid pathology RAI RTx Recurrence Follow-up 
(mon)Cyst Thyroid
1 BTT with CCND Central 
neck
Exam No Rt.: VI, 
Lt.: V
1.2 PTC arising in 
thyroglossal duct 
cyst
Rt. thyroid: PTC (1.3 cm) Yes No No 94
Lt. MRND Lt. thyroid: PTC (1.1 cm)
Shaving off of trachea 
& RLN
Metastatic carcinoma in 
4 out of 34 lymph nodes




Mass No Rt.: VI 2.2 PTC arising in 
thyroglossal duct 
cyst
Rt. thyroid: PTC (1.0 cm) Yes No No 80
Lt. thyroid: Free




Mass No Lt.: VI 2.5 Thyroglossal duct 
cyst containing PTC
Rt. thyroid: Free Yes No No 39
Lt. thyroid: PTC (1.3 cm)
4 Sistrunk operation Central 
neck
Exam No Lt.: VI 1.5 PTC Rt. thyroid: Free Yes No No 25
BTT with CCND Lt. thyroid: PTC (1.0 cm, 
0.3 cm)Lt. MRND




No 0.7 PTC arising in 
thyroglossal duct 
cyst
No lesion No No No 8
6 Sistrunk operation Central 
neck
Mass PTC No 1.8 PTC arising in 
thyroglossal duct 
cyst
No lesion No No No 28
7 Sistrunk operation Central 
neck
Exam No No 0.7 PTC No lesion No No No 57
8 Sistrunk operation Central 
neck
Exam No Rt.: II, 
Lt.: II
0.6 PTC arising in 
thyroglossal duct 
cyst
Rt. thyroid: NIFTP (1.5 
cm)
No No No 1
Rt. thyroidectomy with 
CCND
FNA = fine-needle aspiration; TGDC = thyroglossal duct cyst; RAI = radioactive iodine; RTx = radiation therapy; BTT = bilateral total thyroidectomy; CCND = 
central compartment lymph node dissection; MRND = modified radical neck dissection; RLN = recurrent laryngeal nerve; PTC = papillary thyroid cancer; NIFTP = 
noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
Among all cases, only Sistrunk operation was performed in three cases. In four cases, cystic 
lesion and thyroid nodules were identified on ultrasound images, and thyroidectomy and 
Sistrunk operation were performed together. In the first case, thyroid nodules and lateral 
neck lymph node were seen in the ultrasound image, but cystic lesion was not visible. 
Furthermore, lateral neck node metastasis was confirmed by FNA test before surgery. Thus, 
total thyroidectomy and modified radical neck dissection (MRND) were performed. In 
another patient, lateral neck node metastasis was also confirmed and MRND was performed.
Four patients who underwent total thyroidectomy and Sistrunk operation did not have malignant 
disease or recurrence between 25 and 94 months (average 60 months). All patients received RAI 
treatment, and none received radiation therapy (RTx) No patients had distant metastasis.
DISCUSSION
TGDC is the most common midline neck cyst and is a congenital anomaly. It accounts for 70% 
of congenital neck masses (8). In general, TGDC is benign but has been reported to undergo 
malignant transformation in approximately 1% of cases (9,10). Weiss and Orlich (9) reported 
that thyroid cysts and the thyroid gland were associated with thyroid papillary cancer in 11.4% 
of 115 cases, and Chrisoulidou et al. (11) reported the same in 66% of six cases. In our study, 
four (50%) out of eight patients with TGDC had papillary thyroid cancer. Carcinoma arising 
from TGDC has an excellent prognosis and a metastasis rate of less than 2% (12).
In terms of sex distribution at the two tertiary institutions in our series, women outnumbered 
men. Türkyilmaz et al. (13) also reported a high distribution among women. However, some 
studies have reported that TGDC has the same distribution between men and women (14). In 
our study, seven out of eight patients with carcinomas arising from TGDC were women. This 
distribution might be due to geographic differences in Korea, where thyroid papillary cancer 
more commonly occurs in women than in men.
The main cause of patients visiting the hospital for TGDC is a mass that is visible, palpable, 
or infected. In cases where a mass is present, it is usually solitary, midline, and moves with 
swallowing, and when infected, it causes pain, fever, dysphagia, dyspnea, or could lead to a 
fistula (15). Among the patients we analyzed, four patients (50%) had been treated because of 
the presence of a palpable mass.
A detailed clinical history must be obtained to make an accurate diagnosis before surgery. 
Making a diagnosis before surgery is difficult; therefore, imaging tests, such as ultrasound, 
neck CT, and magnetic resonance imaging, which help to determine whether the thyroid 
tissue is normal, are mainly performed. In general, an imaging test cannot confirm a 
malignant disease; therefore, an FNA test is performed as well. However, due to the 
hypocellularity of samples, only 66% of cases show accurate results (16). In our study, FNA 
test was performed in only two of the seven cases where a cystic lesion was detected upon 
preoperative imaging examination. A diagnosis of PTC was made in one case, and in the 
other case, a diagnosis could not be made due to hypocellularity.
Much controversy exists over the extent of surgical treatment for carcinomas arising from 
TGDC. Some consider a Sistrunk operation as sufficient, while others recommend both a 
Sistrunk operation and a total thyroidectomy (12,14,17). Sistrunk operation was introduced 
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in 1920 by Sistrunk as a procedure for removing structures that make up a cyst, its tract, 
the middle part of the hyoid bone, and the base of the tongue (18). The recurrence rate was 
reduced to 3%–6% compared with that of the previous techniques in which a simple incision 
is made to drain the cyst and remove the middle part of the hyoid bone along with cyst. 
Currently, the Sistrunk operation is the standard surgical technique that is performed (13,19). 
Sistrunk operation is a safe procedure with few complications. The major complications 
(abscess, hematoma, nerve palsies etc.) are known to be extremely rare (15).
Most surgeons determine surgical strategies based on risk stratification and perform Sistrunk 
operation in clinically low risk patients with normal thyroid glands. Total thyroidectomy is 
also performed in high-risk patients and in patients with a positive thyroid FNA test. This 
is because performing total thyroidectomy generally is a way to cause lifelong hormone 
replacement therapy and possible complications in low-risk patients. In a review study 
involving more than five cases, the average rate of Sistrunk operation and total thyroidectomy 
performed together was 46.3% (20).
In our study, 50% (four out of eight cases) were had thyroid cancer. Sistrunk operation and 
total thyroidectomy were performed in three cases, right total thyroidectomy and Sistrunk 
operation were performed together in one case, and only Sistrunk operation was performed 
in three cases. In two cases, modified radical neck dissection was performed because a 
metastasis node was present in the lateral part of the neck.
CONCLUSION
Carcinomas arising from TGDCs are rare and were reported in only eight cases out of the 
346 cases we reviewed. An initial evaluation, which is important in determining the extent 
of surgery, should be properly performed because of lack of a clear guideline on the extent 
of surgery or the need for adjuvant therapy, such as RAI or RTx. Therefore, in order to make 
accurate preoperative diagnosis of malignancies and to determine the extent of surgery, 
TGDC, thyroid ultrasound scans and FNA tests should be performed for patients who have 
been clinical diagnosed with TGDC.
The analysis of the results of the cases reviewed here suggests that the surgical method and 
conservative management suitable for each patient should be performed according to the 
preoperative examination results of TGDC, and continuous observation and examination 
are required.
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